Immatics (IMTX) EBT (2019 - 2025)
Immatics' (IMTX) quarterly EBT came in at -$41.4 million in Q4 2025, down 189.53% year-on-year from $46.2 million in Q4 2024, and up 30.12% quarter-over-quarter from -$59.2 million in Q3 2025.
Immatics (IMTX) EBT (2019 - 2025) Analysis & Trends
Immatics has disclosed EBT across 7 years of filings, most recently posting -$41.4 million for Q4 2025.
- EBT for Q4 2025 came in at -$41.4 million, down 189.53% year-over-year; the trailing twelve-month figure through Dec 2025 was -$224.4 million (down 1094.55% YoY), and the FY2025 annual result was -$224.2 million, down 1082.87% from the prior year.
- EBT came in at -$41.4 million for Q4 2025 at Immatics, up from -$59.2 million in the prior quarter.
- In the past five years, EBT ranged from a high of $96.1 million in Q1 2022 to a low of -$80.8 million in Q2 2025.
- The 5-year median for EBT is -$24.0 million (2023), against an average of -$18.3 million.
- Across the five-year window, EBT jumped 449.38% in 2022 and slumped 2196.9% in 2025, its largest moves.
- Immatics' EBT stood at -$19.2 million in 2021, then jumped by 44.68% to -$10.6 million in 2022, then sank by 164.82% to -$28.1 million in 2023, then surged by 264.36% to $46.2 million in 2024, then tumbled by 189.53% to -$41.4 million in 2025.
- The last three EBT figures came in at -$41.4 million (Q4 2025), -$59.2 million (Q3 2025), and -$80.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.18 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.31 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.48 Mn |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | -41.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -41.40 Mn |
| Sep 30, 2025 | -59.24 Mn |
| Jun 30, 2025 | -80.76 Mn |
| Mar 31, 2025 | -42.97 Mn |
| Dec 31, 2024 | 46.24 Mn |
| Sep 30, 2024 | -2.58 Mn |
| Jun 30, 2024 | -19.22 Mn |
| Mar 31, 2024 | -1.87 Mn |
| Dec 31, 2023 | -28.13 Mn |
| Sep 30, 2023 | -28.84 Mn |
| Jun 30, 2023 | -26.80 Mn |
| Mar 31, 2023 | -21.20 Mn |
| Dec 31, 2022 | -10.62 Mn |
| Sep 30, 2022 | -20.55 Mn |
| Jun 30, 2022 | -13.70 Mn |
| Mar 31, 2022 | 96.14 Mn |
| Dec 31, 2021 | -19.20 Mn |
| Sep 30, 2021 | -32.08 Mn |
| Jun 30, 2021 | -31.95 Mn |
| Mar 31, 2021 | -27.52 Mn |